F Star, An Invo X Company
Biotechnology, Babraham Research Campus, Cambridge, Delaware, 19803, United States, 51-200 Employees
Phone Number: 16*********
Who is F-STAR, AN INVOX COMPANY
F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F...
Read More
-
Headquarters: Babraham Research Campus, Cambridge, Delaware, 19803, United States
-
Date Founded: 2002
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from F-STAR, AN INVOX COMPANY
F-star, an invoX company Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding F-star, an invoX company
Answer: F-star, an invoX company's headquarters are located at Babraham Research Campus, Cambridge, Delaware, 19803, United States
Answer: F-star, an invoX company's phone number is 16*********
Answer: F-star, an invoX company's official website is https://f-star.com
Answer: F-star, an invoX company's revenue is $25 Million to $50 Million
Answer: F-star, an invoX company's SIC: 2834
Answer: F-star, an invoX company's NAICS: 325412
Answer: F-star, an invoX company has 51-200 employees
Answer: F-star, an invoX company is in Biotechnology
Answer: F-star, an invoX company contact info: Phone number: 16********* Website: https://f-star.com
Answer: F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody discovery platform is protected by an extensive intellectual property estate, with over 500 granted patents and pending patent applications relating to its platform technology and product pipeline. The Company has attracted multiple partnerships with biopharma targeting significant unmet needs across several areas, including oncology, immunology, and CNS.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month